TabsDetailsBasic DetailsDate: Wednesday, August 22, 2018Type: PresentationMedical Product: alemtuzumab, daclizumab, dalfampridine, dimethyl fumarate, fingolimod, glatiramer acetate, interferon beta-1A, interferon beta-1B, mitoxantrone, natalizumab, peginterferon beta-1a, teriflunomideMaterials: Use of Multiple Sclerosis Drugs Among Live Birth Pregnancies in the United StatesAdditional InformationInformationHost: 34th International Conference on Pharmacoepidemiology & Therapeutic Risk ManagementRelated Assessment(s): Abstracts of the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Prague Congress Centre, Prague, Czech Republic, August 22–26, 2018 | Abstract 63 ContributorsPresenter(s): Danijela Stojanovic, Mayura Shinde, Nicole Haug, Mohamed Mohamoud, Leyla Sahin, Genna Panucci, Rajani Rajbhandari, Lockwood Taylor
